Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib.

Saved in:
Bibliographic Details
Title: Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib.
Authors: Lee CJ; Department of Oncology, Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium., Schöffski P; Department of Oncology, Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium.; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Modave E; Center for Cancer Biology, VIB, Leuven, Belgium.; Department of Human Genetics, Laboratory of Translational Genetics, KU Leuven, Leuven, Belgium., van Wezel T; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Boeckx B; Center for Cancer Biology, VIB, Leuven, Belgium.; Department of Human Genetics, Laboratory of Translational Genetics, KU Leuven, Leuven, Belgium., Sufliarsky J; National Cancer Institute, Bratislava, Slovakia., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Blay JY; Department of Medical Oncology, Center Léon Bérard/Université Claude Bernard Lyon Institute, Lyon, France., Debiec-Rychter M; Department of Human Genetics, Laboratory for Genetics of Malignant Disorders, KU Leuven, Belgium., Sciot R; Department of Pathology, University Hospitals Leuven and KU Leuven, Leuven, Belgium., Bovée JVMG; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Lambrechts D; Center for Cancer Biology, VIB, Leuven, Belgium.; Department of Human Genetics, Laboratory of Translational Genetics, KU Leuven, Leuven, Belgium., Wozniak A; Department of Oncology, Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium. agnieszka.wozniak@kuleuven.be.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Dec 15; Vol. 27 (24), pp. 6737-6748. Date of Electronic Publication: 2021 Sep 22.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-21-1165